Lysatpharma GmbH
PrivateLast Round
Seed
Jan 1, 2020
Company Overview
Lysatpharma GmbH is a biotechnology company that develops novel therapeutic approaches for the treatment of acute and chronic inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lysatpharma GmbH Comparables
Compare Lysatpharma GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exogenus Therapeutics | 84% | |
| EXO Biologics | 80% | |
| EVerZom | 79% |
Lysatpharma GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 1, 2020 |
Lysatpharma GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xlife Sciences AG | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2020
Seed round with participation from Xlife Sciences AG.
Lysatpharma GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lysatpharma GmbH's valuation, stock price, and market status.
Is Lysatpharma GmbH a public or private company?
Lysatpharma GmbH is a private company.
What is the current stock price of Lysatpharma GmbH?
Lysatpharma GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is Lysatpharma GmbH worth (valuation)?
Valuation information for Lysatpharma GmbH is not publicly available.
Can I buy Lysatpharma GmbH stock?
Lysatpharma GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lysatpharma GmbH's last funding round?
Funding round information for Lysatpharma GmbH is not publicly available.
Who are the main investors in Lysatpharma GmbH?
Investor information for Lysatpharma GmbH is not publicly disclosed.
Will Lysatpharma GmbH IPO soon?
No public IPO plans have been announced for Lysatpharma GmbH.
How can I track Lysatpharma GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lysatpharma GmbH's secondary market activity and sign up for updates.